skip to main content
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Refinado por: Lista de Todas as Versões remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Artigo
Adicionar ao Meu Espaço

Safety, Tolerability, and Pharmacokinetics of a Capsule Formulation of DRF‐1042, a Novel Camptothecin Analog, in Refractory Cancer Patients in a Bridging Phase I Study

Chatterjee, Arani ; Digumarti, Raghunadharao ; Katneni, Kasiram ; Upreti, Vijay V. ; Mamidi, Rao N. V. S. ; Mullangi, Ramesh ; Surath, Anjna ; Srinivas, Maddali L. ; Uppalapati, Srihari ; Jiwatani, Sangeeta ; Srinivas, Nuggehally R.

Journal of Clinical Pharmacology, April 2005, Vol.45(4), pp.453-460 [Periódico revisado por pares]

John Wiley & Sons, Inc.

Texto completo disponível

2
Material Type:
Artigo
Adicionar ao Meu Espaço

Safety, tolerability, and pharmacokinetics of a capsule formulation of DRF-1042, a novel camptothecin analog, in refractory cancer patients in a bridging phase I study

Chatterjee, Arani ; Digumarti, Raghunadharao ; Katneni, Kasiram ; Upreti, Vijay V. ; Mamidi, Rao N. V. S. ; Mullangi, Ramesh ; Surath, Anjna ; Srinivas, Maddali L. ; Uppalapati, Srihari ; Jiwatani, Sangeeta ; Srinivas, Nuggehally R.

Journal of Clinical Pharmacology, April, 2005, Vol.45(4), p.453(8) [Periódico revisado por pares]

Cengage Learning, Inc.

Texto completo disponível

3
Material Type:
Artigo
Adicionar ao Meu Espaço

Safety, Tolerability, and Pharmacokinetics of a Capsule Formulation of DRF-1042, a Novel Camptothecin Analog, in Refractory Cancer Patients in a Bridging Phase I Study

Chatterjee, V., Arani ; Digumarti, N. V. S., Raghunadharao ; Katneni, L., Kasiram ; Upreti, R., Vijay ; Mamidi, R., Rao ; Mullangi, R., Ramesh ; Surath, R., Anjna ; Srinivas, R., Maddali ; Uppalapati, R., Srihari ; Jiwatani, R., Sangeeta ; Srinivas, R., Nuggehally

The Journal of Clinical Pharmacology, 2005, Vol.45(4), pp.453-460 [Periódico revisado por pares]

Copyright © 2013 Lippincott Williams & Wilkins. All rights reserved.

Texto completo disponível

4
Safety, Tolerability, and Pharmacokinetics of a Capsule Formulation of DRF-1042, a Novel Camptothecin Analog, in Refractory Cancer Patients in a Bridging Phase I Study
Material Type:
Artigo
Adicionar ao Meu Espaço

Safety, Tolerability, and Pharmacokinetics of a Capsule Formulation of DRF-1042, a Novel Camptothecin Analog, in Refractory Cancer Patients in a Bridging Phase I Study

Chatterjee, Arani ; Digumarti, Raghunadharao ; Katneni, Kasiram ; Upreti, Vijay V. ; Mamidi, Rao N. V. S. ; Mullangi, Ramesh ; Surath, Anjna ; Srinivas, Maddali L. ; Uppalapati, Srihari ; Jiwatani, Sangeeta ; Srinivas, Nuggehally R.

The Journal of Clinical Pharmacology, 04/2005, Vol.45(4), pp.453-460 [Periódico revisado por pares]

Sage Publications (via CrossRef)

Texto completo disponível

5
Material Type:
Artigo
Adicionar ao Meu Espaço

Safety, tolerability, and pharmacokinetics of a capsule formulation of DRF-1042, a novel camptothecin analog, in refractory cancer patients in a bridging phase I study

Chatterjee, Arani ; Digumarti, Raghunadharao ; Katneni, Kasiram ; Upreti, Vijay V ; Mamidi, Rao N V S ; Mullangi, Ramesh ; Surath, Anjna ; Srinivas, Maddali L ; Uppalapati, Srihari ; Jiwatani, Sangeeta ; Srinivas, Nuggehally R

Journal of clinical pharmacology, April 2005, Vol.45(4), pp.453-60 [Periódico revisado por pares]

MEDLINE/PubMed (U.S. National Library of Medicine)

Texto completo disponível

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Buscando em bases de dados remotas. Favor aguardar.